Federal Circuit Summary -
Before Moore, Chen, and Hughes. Appeal from the United States District Court for the District of Delaware.
Summary: Obviousness-type double patenting does not invalidate an otherwise validly...more
12/14/2018
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Double Patent ,
Judgment on the Pleadings ,
Novartis ,
Obviousness ,
Obviousness-Type Double Patenting (ODP) ,
Patent Expiration ,
Patent Filings ,
Patent Infringement ,
Patent Invalidity ,
Patent Term Adjustment ,
Patent Term Extensions ,
Patent Terms ,
Patents ,
Pharmaceutical Patents ,
Uruguay Round Agreements Act (URAA)